Retraction Volume 12, Issue 20 pp 20930

Retraction: miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling

Zhi-Chao Wang1, *, , Yan Li2, *, , Ke-Liang Wang1, *, , Lu Wang1, , Bo-Sen You1, , Dan-Feng Zhao1, , Zhong- Qing Liu1, , Rui-Zhe Fang1, , Jia-Qi Wang1, , Wei Zhang1, , Jin-Ming Zhang1, , Wan-Hai Xu1, ,

  • 1 Heilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China
  • 2 Department of Anesthesia, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China
* Equal contribution

Received: September 8, 2020       Accepted: October 12, 2020       Published: October 31, 2020      

https://doi.org/10.18632/aging.104212
How to Cite
Retraction for: Aging (Albany NY). 2020; 12:14418-14433. https://doi.org/10.18632/aging.103485  PMID: 32694237

Copyright: © 2020 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.